clofibrate has been researched along with Alcoholic Liver Diseases in 1 studies
angiokapsul: contains clofibrate & insoitolnicotinate
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with clofibrate, a PPARalpha-activating ligand, led to a marked decrease in fatty liver and complete abrogation of necroinflammatory changes in FE rats." | 1.32 | Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. ( Bass, NM; Dannenberg, AJ; Jokelainen, K; Nanji, AA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nanji, AA | 1 |
| Dannenberg, AJ | 1 |
| Jokelainen, K | 1 |
| Bass, NM | 1 |
1 other study available for clofibrate and Alcoholic Liver Diseases
| Article | Year |
|---|---|
Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
Topics: Acyl-CoA Oxidase; Animals; Carrier Proteins; Clofibrate; Cyclooxygenase 2; Ethanol; Fatty Acid-Bindi | 2004 |